Cargando…

Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center

BACKGROUND: Renal amyloidosis is one of the main differential diagnoses of nephrotic proteinuria in adults and the elderly. The aim of this study with the most important series in our country is to contribute to the epidemiological, clinical, and etiological study of the renal amyloidosis. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaaroud, Hayet, Harzallah, Amel, Hajji, Mariem, Chargui, Soumaya, Barbouch, Samia, Turki, Sami, Trabelsi, Raja, Goucha, Rim, Ben Moussa, Fatma, Ben Maiz, Hedi, Ben Hamida, Fethi, Abderrahim, Ezzeddine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314002/
https://www.ncbi.nlm.nih.gov/pubmed/35898389
http://dx.doi.org/10.1155/2022/8493479
_version_ 1784754213363908608
author Kaaroud, Hayet
Harzallah, Amel
Hajji, Mariem
Chargui, Soumaya
Barbouch, Samia
Turki, Sami
Trabelsi, Raja
Goucha, Rim
Ben Moussa, Fatma
Ben Maiz, Hedi
Ben Hamida, Fethi
Abderrahim, Ezzeddine
author_facet Kaaroud, Hayet
Harzallah, Amel
Hajji, Mariem
Chargui, Soumaya
Barbouch, Samia
Turki, Sami
Trabelsi, Raja
Goucha, Rim
Ben Moussa, Fatma
Ben Maiz, Hedi
Ben Hamida, Fethi
Abderrahim, Ezzeddine
author_sort Kaaroud, Hayet
collection PubMed
description BACKGROUND: Renal amyloidosis is one of the main differential diagnoses of nephrotic proteinuria in adults and the elderly. The aim of this study with the most important series in our country is to contribute to the epidemiological, clinical, and etiological study of the renal amyloidosis. METHODS: In a retrospective study carried out between 1975 and 2019, 310 cases of histologically proven and typed renal amyloidosis were selected for this study. RESULTS: There were 209 men and 101 women with a mean age of 53.8 ± 15.4 years (range, 17–84 years). Of the 310 cases, 255 (82.3%) were diagnosed with AA renal amyloidosis and 55 (17.7%) with non-AA amyloidosis. Infections were the main cause of AA amyloidosis, and tuberculosis was the most frequent etiology. The period from the onset of the underlying disease to diagnosis of the renal amyloidosis was an average of 177 months. The most frequent manifestations at the time of diagnosis were nephrotic syndrome (84%), chronic renal failure (30.3%), and end-stage renal disease (37.8%). After a medium follow-up of 16 months (range, 0–68 months), mortality occurred in 60 cases. CONCLUSIONS: Given the high frequency of AA amyloidosis in our country, awareness of the proper management of infectious and chronic inflammatory diseases remains a priority in reducing the occurrence of this serious disease.
format Online
Article
Text
id pubmed-9314002
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93140022022-07-26 Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center Kaaroud, Hayet Harzallah, Amel Hajji, Mariem Chargui, Soumaya Barbouch, Samia Turki, Sami Trabelsi, Raja Goucha, Rim Ben Moussa, Fatma Ben Maiz, Hedi Ben Hamida, Fethi Abderrahim, Ezzeddine Int J Nephrol Research Article BACKGROUND: Renal amyloidosis is one of the main differential diagnoses of nephrotic proteinuria in adults and the elderly. The aim of this study with the most important series in our country is to contribute to the epidemiological, clinical, and etiological study of the renal amyloidosis. METHODS: In a retrospective study carried out between 1975 and 2019, 310 cases of histologically proven and typed renal amyloidosis were selected for this study. RESULTS: There were 209 men and 101 women with a mean age of 53.8 ± 15.4 years (range, 17–84 years). Of the 310 cases, 255 (82.3%) were diagnosed with AA renal amyloidosis and 55 (17.7%) with non-AA amyloidosis. Infections were the main cause of AA amyloidosis, and tuberculosis was the most frequent etiology. The period from the onset of the underlying disease to diagnosis of the renal amyloidosis was an average of 177 months. The most frequent manifestations at the time of diagnosis were nephrotic syndrome (84%), chronic renal failure (30.3%), and end-stage renal disease (37.8%). After a medium follow-up of 16 months (range, 0–68 months), mortality occurred in 60 cases. CONCLUSIONS: Given the high frequency of AA amyloidosis in our country, awareness of the proper management of infectious and chronic inflammatory diseases remains a priority in reducing the occurrence of this serious disease. Hindawi 2022-07-18 /pmc/articles/PMC9314002/ /pubmed/35898389 http://dx.doi.org/10.1155/2022/8493479 Text en Copyright © 2022 Hayet Kaaroud et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kaaroud, Hayet
Harzallah, Amel
Hajji, Mariem
Chargui, Soumaya
Barbouch, Samia
Turki, Sami
Trabelsi, Raja
Goucha, Rim
Ben Moussa, Fatma
Ben Maiz, Hedi
Ben Hamida, Fethi
Abderrahim, Ezzeddine
Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center
title Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center
title_full Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center
title_fullStr Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center
title_full_unstemmed Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center
title_short Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center
title_sort renal amyloidosis: epidemiological, clinical, and laboratory profile in adults from one nephrology center
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314002/
https://www.ncbi.nlm.nih.gov/pubmed/35898389
http://dx.doi.org/10.1155/2022/8493479
work_keys_str_mv AT kaaroudhayet renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter
AT harzallahamel renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter
AT hajjimariem renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter
AT charguisoumaya renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter
AT barbouchsamia renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter
AT turkisami renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter
AT trabelsiraja renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter
AT goucharim renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter
AT benmoussafatma renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter
AT benmaizhedi renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter
AT benhamidafethi renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter
AT abderrahimezzeddine renalamyloidosisepidemiologicalclinicalandlaboratoryprofileinadultsfromonenephrologycenter